Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2004Molecular Cancer Therapeutics

Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents

View Full Paper
Ask AI
Bookmark
Share

Authors

HGHenriette GourdeauLLLorraine LeblondBHBettina A. Hamelin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gourdeau et al. (2004) studied this question.

synapsesocial.com/papers/69dd5d517808b00a4799d286https://doi.org/10.1158/1535-7163.1375.3.11
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials2001 · 861 citations
  2. 2Anticancer Drug Development: Preclinical Screening, Clinical Trials and Approval2004 · 238 citations
  3. 3Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity2004 · 205 citations